drugset / Trial / NCT00582205

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

NCT00582205 ↗

Phase 2 Terminated 21 enrolled University of Oklahoma
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate giving chemotherapy drugs directly into the abdomen (belly) along with intravenous administration.

Timeline

Start
2006-01
Primary completion
2011-12
Completion
2011-12

Outcome

Outcome not reported

Stopped: “Study completed per investigator.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 50 mg/m2 Other
Subject Paclitaxel Small molecule 135 mg/m2 Intravenous